BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7863629)

  • 1. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
    Lubenko A; Contreras M; Rodeck CH; Nicolini U; Savage J; Chana H
    Vox Sang; 1994; 67(3):291-8. PubMed ID: 7863629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analyses of the subclasses of red cell IgG antibodies.
    Lynen R; Neuhaus R; Schwarz DW; Simson G; Riggert J; Mayr WR; Köhler M
    Vox Sang; 1995; 69(2):126-30. PubMed ID: 8585193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative assay for subclassing IgG alloantibodies implicated in hemolytic disease of the newborn.
    Thomas NC; Shirey RS; Blakemore K; Kickler TS
    Vox Sang; 1995; 69(2):120-5. PubMed ID: 8585192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn.
    Palfi M; Hildén JO; Gottvall T; Selbing A
    Am J Reprod Immunol; 1998 May; 39(5):323-8. PubMed ID: 9602250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of IgG subtypes in maternal anti-D sera and their prognostic value in Rh haemolytic disease of the new-born.
    Iyer YS; Kulkarni SV; Gupte SC
    Acta Haematol; 1992; 88(2-3):78-81. PubMed ID: 1466203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies.
    Ukita M; Takahashi A; Nunotani T; Kihana T; Watanabe S; Yamada N
    Vox Sang; 1989; 56(3):181-6. PubMed ID: 2728395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assays to predict the severity of hemolytic disease of the newborn.
    Hadley AG
    Transfus Med Rev; 1995 Oct; 9(4):302-13. PubMed ID: 8541713
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn.
    Pollock JM; Bowman JM
    Vox Sang; 1990; 59(3):176-9. PubMed ID: 2124753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of maternofetal transport of immunoglobulins during human pregnancy.
    Malek A; Sager R; Kuhn P; Nicolaides KH; Schneider H
    Am J Reprod Immunol; 1996 Nov; 36(5):248-55. PubMed ID: 8955500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of red cell maternal antibodies by chemiluminescence.
    Downing I; Bromilow IM; Templeton JG; Fraser RH
    Vox Sang; 1996; 71(4):226-32. PubMed ID: 8958647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass.
    Einhorn MS; Granoff DM; Nahm MH; Quinn A; Shackelford PG
    J Pediatr; 1987 Nov; 111(5):783-8. PubMed ID: 3312554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy.
    Malek A; Sager R; Schneider H
    Am J Reprod Immunol; 1994 Aug; 32(1):8-14. PubMed ID: 7945815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
    Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
    Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental transfer of immunoglobulin G subclasses.
    Garty BZ; Ludomirsky A; Danon YL; Peter JB; Douglas SD
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):667-9. PubMed ID: 8556518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of hemolytic disease in the fetus and newborn.
    Bowman J
    Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of IgG subclasses on DAT positive RBC membranes by flow cytometry (FC).
    Asmussen C; Gutensohn K; Wittkopf D; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1996; 33():35-9. PubMed ID: 8865935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.